The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Hypromellose

Hypromellose

Hypromellose, also known as hydroxypropyl methylcellulose, is a semisynthetic, partially substituted cellulose ether used as a pharmaceutical excipient and viscosity-increasing agent.
It is commonly employed in formulations for controlled drug release, ocular delivery, and topical applications.
PubCompare.ai's AI-driven platform helps researchers identify the most repoducible and accurate hypromellose research methods from literature, preprints, and patents, empowering reliable studies.
Explore this seamless solution to optimize your hypromellose-related research needs.

Most cited protocols related to «Hypromellose»

BRafCA, Tyr::CreER and Ptenlox4-5 mice were genotyped as previously described 17 (link),20 (link),24 (link). Cre-mediated conversion of BRafCA to BRafVE and the deletion of exons 4 and 5 of Pten were assessed by PCR as previously described. Topical administration of 4-hydroxytamoxifen (4-HT) was performed by preparing a 25-50mg/ml (65-130mM) solution of 4-HT (70% Z-isomer, Sigma) in DMSO and applying enough solution to wet the right ear, right flank and tail with a small paint brush on post-natal days 2, 3, and 4. For localized melanoma induction on the back skin, adult (6-8 weeks of age) mice were treated topically with 1-2 μl of 1.9mg/ml (5mM) 4-HT at 6-8 weeks of age using a similar protocol. Generalized induction in adult mice was performed by intra-peritoneal injection of 1mg of tamoxifen/40g mouse on 3 consecutive days. In this case tamoxifen was prepared as a 10mg/ml suspension in peanut oil. PD352901 was dissolved in 0.5%(w/v) Hydroxy-propyl-methylcellulose, 0.2%(v/v) Tween 80 (Sigma) and administered to mice daily by oral gavage at a dose of 12.5mg/kg. Rapamycin (LC Laboratories, Woburn, MA) was suspended in 0.5%(w/v) methylcellulose and administered to mice daily by oral gavage at a dose of 7.5mg/kg. Control animals in the melanoma prevention studies were administered with the relevant solvent. Tissues were prepared for analysis as previously described 17 (link),20 (link)
Publication 2009
Administration, Topical Adult Animals Deletion Mutation Exons Familial Atypical Mole-Malignant Melanoma Syndrome hydroxytamoxifen Hypromellose Injections, Intraperitoneal Isomerism Melanoma Methylcellulose Mice, House Peanut Oil PTEN protein, human Sirolimus Solvents Sulfoxide, Dimethyl Tail Tamoxifen Tissues Tube Feeding Tween 80

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Antidepressive Agents beta-Arrestin 2 Brain Corticosterone Cortisone Cyclodextrins Fluoxetine Fluoxetine Hydrochloride Hypromellose Imipramine Hydrochloride Light Mice, House Reboxetine Tube Feeding
All mouse experiments were approved by the Cold Spring Harbor animal care and use committee. For conditional RNAi experiments in vivo, Tet-on MLL-AF9/NrasG12D leukaemia cells were transduced with TRMPV-Neo-shRNA constructs, followed by transplantation into sub-lethally irradiated recipient mice, as described previously10 . For shRNA induction, animals were treated with doxycycline in both drinking water (2 mg ml−1 with 2% sucrose; Sigma-Aldrich) and food (625 mg kg−1, Harlan laboratories). For JQ1 treatment trials, a stock of 100 mg ml−1 JQ1 in DMSO was diluted 20-fold by dropwise addition of a 10% 2-hydroxypropyl-β-cyclodextrin carrier (Sigma) under vortexing, yielding a 5 mg ml−1 final solution. Mice were intraperitoneally injected daily with freshly diluted JQ1 (50 or 100 mg kg−1) or a similar volume of carrier containing 5% DMSO.
Publication 2011
Animals Cells Common Cold Cyclodextrins Doxycycline Food Hypromellose Leukemia Mice, House RNA Interference Short Hairpin RNA Sucrose Sulfoxide, Dimethyl Transplantation
Drugs were administered according to a randomised latin-square design. CNO (Enzo Lifesciences, NY, USA) and CLZ (Sigma Aldrich, UK) were dissolved in hydrochloric acid (1:15) and 40% hydroxypropyl-β-cyclodextrine (1:10). The pH was adjusted to 6.5–7.5. Cmpd-21 (HelloBio, UK) was dissolved in 0.9% saline. The dose range and pre-treatment time were selected based on in-house pharmacokinetic data and published literature32 (link). Since a fully automated data acquisition system was used, the experimenter was not blinded to treatment. All drugs were administered i.p. at a volume of 10 ml/kg 10 min before the start of the behavioural test. The applied doses were 3.5 or 10 mg/kg for CNO, 0.1, 0.3 or 1 mg/kg for CLZ, and 0.3, 1 or 3 mg/kg for Cmpd-21, in addition to vehicle in each case. Mice were habituated to injections by i.p. administration of 0.9% saline 3–5 days before drug administration.
Publication 2019
Behavior Test Dysplasia, Campomelic Hydrochloric acid Hypromellose Mice, House Normal Saline Pharmaceutical Preparations
Slices were perfused with ACSF, which was heated to 35–37°C, equilibrated with 95% O2/5% CO2 and contained (in mM): 126 NaCl, 26 NaHCO3, 3 KCl, 1.25
NaH2PO4, 1.6 CaCl2, 1.5 MgSO4, 10 glucose, 0.05 D-(–)-2-amino-5-phosphonopentanoic acid (APV), 0.02 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 0.002 (2S)-3-{[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl)(phenylmethyl)phosphinic acid (CGP 55845). APV, DNQX and CGP55845 were used to block NMDA, AMPA/kainate and GABAB receptors, respectively, so that GABAA receptor-mediated currents could be studied in relative isolation (Bevan et al., 2002 (link); Hallworth and Bevan, 2005 (link)). Miniature inhibitory postsynaptic currents (mIPSCs) were recorded in the additional presence of 0.5 µM tetrodotoxin. In some cases sulpiride (2 µM) was added to block D2 dopamine receptors. Drugs were purchased from Abcam except for sulpiride, which was obtained from Tocris.
Somatic patch clamp recordings were obtained under visual guidance (Axioskop FS2, Zeiss) using computer-controlled manipulators (Luigs & Neumann) and a Multiclamp 700B amplifier and digidata 1440A digitizer controlled by PClamp 10 (Molecular Devices). Pipettes contained (in mM): 135 CsCl, 3.6 NaCl, 1 MgCl2, 10 HEPES, 10 QX-314, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) or 130 Kgluconate, 3.6 Nagluconate, 1 MgCl2, 10 HEPES, 10 QX-314, TEA-Cl 5, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) for the recording of GABAA receptor-mediated mIPSCs and evoked currents, respectively. mIPSCs were recorded at −60 mV. Evoked IPSCs and isoguvacine-evoked current were recorded at −50 mV. Weighted decay kinetics ofmIPSCs were calculated from τ decay = (A1*τ1 + A2*τ2)/(A1 + A2) where A and τ refer to the amplitude and decay constants, respectively, of biexponential fits of mIPSCs. Data were analyzed with Clampfit 10 (Molecular Devices), Igor Pro 6 (Wavemetrics) and Origin 8 (OriginLab).
Publication 2012
6,7-dinitroquinoxaline-2,3-dione alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Amino Acids Bicarbonate, Sodium Cardiac Arrest cesium chloride CGP 55845 CGP55845 Diploid Cell Dopamine D2 Receptor GABA-A Receptor Glucose HEPES Hypromellose Induced Pluripotent Stem Cells Inhibitory Postsynaptic Currents isoguvacine isolation Kainate Kinetics Magnesium Chloride Medical Devices N-Methylaspartate Pharmaceutical Preparations Phosphinic Acids QX-314 Seizures Sodium Chloride Sulfate, Magnesium Sulpiride Tetrodotoxin

Most recents protocols related to «Hypromellose»

Example 4

TABLE 15
Composition of mifepristone tablet 240 mg
Composition H
Ingredientsmg/unit
Mifepristone nano-suspension
Mifepristone240.00
HPMC20.00
Sodium lauryl sulphate6.40
Docusate sodium0.80
Purified waterQ.S.
Intra-granular material
Silicified microcrystalline cellulose280.40
Sodium starch glycolate27.20
Extra-granular material
Microcrystalline cellulose119.6
Sodium starch glycolate20.40
Colloidal silicon dioxide1.8
Magnesium Stearate3.40
Core tablet weight (mg)720.00
Film-coating blend
OPADRY ® II Complete Film Coating21.60
System 85F18422 white
Purified WaterQ.S.
Coated Tablet Weight (mg)741.60
Manufacturing Procedure of Composition H:

Composition H was manufactured according to the following procedure:

  • a) Specified amount of purified water was taken in a suitable container and specified quantity of docusate sodium was added and stirred continuously to obtain a solution.
  • b) Sodium lauryl sulphate was added to the step (a) solution and stirred continuously to obtain a solution.
  • c) Hydroxypropyl methyl cellulose was added to the step (b) solution and stirred continuously to obtain a solution.
  • d) Mifepristone was added to the step (c) solution and stirred for 5 minutes to obtain Mifepristone dispersion.
  • e) Mifepristone dispersion was homogenized using IKA's Ultra TURRAX® homogenizer at 1000 RPM for 15 minutes.
  • f) The above homogenized mifepristone slurry was nano-sized in ball-mill chamber to obtain nano-suspension containing desired particle size of mifepristone. The particle size distribution was measured by using Mastersizer 3000 particle analyser.
  • g) Specified quantities of the silicified microcrystalline cellulose and sodium starch glycolate were dispensed in a bowl and warmed to reach 28° C. to 30° C. temperature.
  • h) The nano-sized mifepristone suspension according to step (f) was sprayed onto the warmed intra-granular material according to step (g). The sprayed granules were dried at a temperature of 50° C. to 65° C. and sieved through 30 number mesh sieve.
  • i) Specified quantities of milled granules of step (h), sodium starch glycolate, microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate were blended and compressed using tablet compression machine. The tablets according to step (i) were coated with suitable coating materials.

Patent 2024
Cytoplasmic Granules Docusate Sodium Hypromellose magnesium stearate microcrystalline cellulose Mifepristone Pharmaceutical Preparations Silicon Silicon Dioxide sodium starch glycolate Sulfate, Sodium Dodecyl
Not available on PMC !

Example 3

Raw materialAmount mg/capsule
vicagrel15
pregaletinized starch49.5
lactose140
sodium carboxymethyl starch20
hydroxypropyl methylcellulose5
waterq.s
sodium stearyl fumarate0.5
total230

The pulverized vicagrel salt was placed with pregelatinized starch, lactose, and sodium carboxymethyl starch in a fluidized bed, fluidized mixing is started for 10 min, and 5% hydroxypropyl methylcellulose is prepared as a binder. At an air inlet temperature of 80° C., the binder was sprayed while maintaining a bed temperature at 40-50° C. The formed particles were dried for 30 min while the bed temperature was maintained at 50-60° C., and were discharged. Sodium stearyl fumarate was added and mixed for 5 min, and the particles were filled into capsules.

Patent 2024
Capsule carboxymethyl starch Fumarate Hypromellose Lactose sodium carboxymethyl starch Sodium Chloride sodium stearyl fumarate Starch vicagrel

Example 133

[Figure (not displayed)]

Step 1: tert-butyl (2S)-2-(3-cyano-3-hydroxypropyl)pyrrolidine-1-carboxylate. To a solution of tert-butyl (S)-2-(3-oxopropyl)pyrrolidine-1-carboxylate (114 mg, 0.5 mmol) in DCM (1 mL) was added Et3N (0.1 mL) and acetone cyanohydrin (0.1 mL, 1.2 mmol). The mixture was stirred at r.t. over night. The solution was concentrated by vacuum and purified by silica gel column to afford the title product (120 mg) as colorless oil. MS: [M+1]+ 255.

Step 2: 2-hydroxy-4-((S)-pyrrolidin-2-yl)butanoic acid. To a solution of tert-butyl (2S)-2-(3-cyano-3-hydroxypropyl)pyrrolidine-1-carboxylate (60 mg, 0.23 mmol) in dioxane (0.8 mL) was added HCl (con., 0.8 mL). The mixture was stirred at 100° C. overnight. After cooling to r.t., dioxane was removed by evaporation. The residue was washed by EtOAc (0.5 mL×2). The aqueous phase was collected and evaporated to give a crude product which was used directly in the next step without purification. MS: [M+1]+ 174.

Step 3: 4-((S)-1-(7,8-dichloro-4-(1H-imidazol-1-yl)quinolin-2-yl)pyrrolidin-2-yl)-2-hydroxybutanoic acid (I-817). The title compound was prepared essentially by the same methods as for I-664. MS: [M+1]+ 435.

Patent 2024
2-hydroxybutyric acid acetone cyanohydrin Anabolism Butyric Acid Dioxanes Hypromellose imidazole pyrrolidine Silica Gel TERT protein, human Vacuum

Example 21

[Figure (not displayed)]

To a solution of (R)-5-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1,3,4-oxadiazole-2-carboxamide (101 mg, 0.21 mmol) in MeOH (7 mL) was added (S)-2-methyloxirane (29 μL, 0.42 mmol) and cesium carbonate (135 mg, 0.42 mmol). The mixture was stirred at 60° C. for 16 h. The reaction mixture was cooled to room temperature and filtered. The filtrate was concentrated and the crude product was purified by silica gel chromatography (DCM:MeOH=10:1) to give 5-(tert-butyl)-N—((R)-2-((S)-2-hydroxypropyl)-8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1,3,4-oxadiazole-2-carboxamide as a yellow solid (50 mg, yield: 44%). ESI-MS (M+H)+: 546.0. 1H NMR (400 MHz, METHANOL-d4) δ: 8.41 (d, J=5.3 Hz, 1H), 8.07-8.02 (m, 2H), 7.97 (s, 1H), 7.63 (s, 1H), 7.48 (d, J=8.5 Hz, 1H), 7.22 (d, J=5.3 Hz, 1H), 5.62-5.53 (m, 1H), 4.33-4.10 (m, 2H), 4.04-3.95 (m, 1H), 3.89 (s, 3H), 3.33-3.27 (m, 2H), 2.58-2.46 (m, 2H), 2.38-2.23 (m, 1H), 2.07-1.95 (m, 1H), 1.48 (s, 9H), 1.15 (d, J=6.3 Hz, 3H).

Patent 2024
1H NMR cesium carbonate Chromatography compound 21 Gel Chromatography Hypromellose Methanol Oxadiazoles propylene oxide pyrazole Silica Gel Silicon Dioxide TERT protein, human

Example 124

[Figure (not displayed)]

Step 1: tert-Butyl (S)-2-(2-oxoethyl)pyrrolidine-1-carboxylate. To a solution of tert-butyl (S)-2-(2-hydroxyethyl)pyrrolidine-1-carboxylate (340 mg, 1.5 mmol) in DCM (6 mL) and pyridine (1 mL) was added DMP (800 mg) at 0° C. The mixture was stirred at r.t. for 2 h and quenched by Na2S2O3/NaHCO3 (sat., 10 mL). The organic phase was concentrated by vacuum and purified by silica gel chromatography to afford the title product (280 mg) as colorless oil. MS: [M+1]+ 214.

Step 2 and step 3 were essentially the same procedure as described above to prepare tert-butyl (S)-2-(3-hydroxypropyl)pyrrolidine-1-carboxylate preparation (Step 1 and Step 2).

Patent 2024
Anabolism Bicarbonate, Sodium Chromatography Gel Chromatography Hypromellose pyridine pyrrolidine Silica Gel Silicon Dioxide TERT protein, human Vacuum

Top products related to «Hypromellose»

Sourced in United States, Germany, United Kingdom, Poland, Canada, Australia, Sao Tome and Principe, Switzerland
2-hydroxypropyl-β-cyclodextrin is a modified form of the naturally occurring cyclodextrin molecule. It is a cyclic oligosaccharide composed of seven glucose units. The hydroxypropyl group is used to increase the solubility and stability of the cyclodextrin.
Sourced in United States, United Kingdom, Germany, Spain, India, China
Hydroxypropyl methylcellulose is a water-soluble, non-ionic cellulose ether that is commonly used as a thickening agent, stabilizer, and binder in various industrial and pharmaceutical applications. It is a versatile material that can be used to modify the physical and rheological properties of aqueous solutions, suspensions, and gels.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, Germany, United Kingdom, India, Italy, France, Sao Tome and Principe, Spain, Poland, China, Belgium, Brazil, Switzerland, Canada, Australia, Macao, Ireland, Chile, Pakistan, Japan, Denmark, Malaysia, Indonesia, Israel, Saudi Arabia, Thailand, Bangladesh, Croatia, Mexico, Portugal, Austria, Puerto Rico, Czechia
Tween 80 is a non-ionic surfactant and emulsifier. It is a viscous, yellow liquid that is commonly used in laboratory settings to solubilize and stabilize various compounds and formulations.
Sourced in United States, Germany, France, United Kingdom
Hydroxypropyl-β-cyclodextrin is a modified form of the naturally occurring cyclodextrin compound. It is a white, water-soluble powder commonly used as an excipient in pharmaceutical and biotechnology applications. Hydroxypropyl-β-cyclodextrin is capable of forming inclusion complexes with a variety of guest molecules, which can help improve their solubility, stability, and bioavailability.
Sourced in United States, United Kingdom, Germany, Singapore, Poland, Australia
Hydroxypropyl methylcellulose (HPMC) is a water-soluble, semi-synthetic, and non-ionic cellulose ether. It is commonly used as a binder, thickening agent, and film-forming material in various pharmaceutical, cosmetic, and food applications.
Sourced in Germany, United States, Italy, India, China, United Kingdom, France, Poland, Spain, Switzerland, Australia, Canada, Brazil, Sao Tome and Principe, Ireland, Belgium, Macao, Japan, Singapore, Mexico, Austria, Czechia, Bulgaria, Hungary, Egypt, Denmark, Chile, Malaysia, Israel, Croatia, Portugal, New Zealand, Romania, Norway, Sweden, Indonesia
Acetonitrile is a colorless, volatile, flammable liquid. It is a commonly used solvent in various analytical and chemical applications, including liquid chromatography, gas chromatography, and other laboratory procedures. Acetonitrile is known for its high polarity and ability to dissolve a wide range of organic compounds.
Sourced in Germany, United States, India, United Kingdom, Italy, China, Spain, France, Australia, Canada, Poland, Switzerland, Singapore, Belgium, Sao Tome and Principe, Ireland, Sweden, Brazil, Israel, Mexico, Macao, Chile, Japan, Hungary, Malaysia, Denmark, Portugal, Indonesia, Netherlands, Czechia, Finland, Austria, Romania, Pakistan, Cameroon, Egypt, Greece, Bulgaria, Norway, Colombia, New Zealand, Lithuania
Sodium hydroxide is a chemical compound with the formula NaOH. It is a white, odorless, crystalline solid that is highly soluble in water and is a strong base. It is commonly used in various laboratory applications as a reagent.
Sourced in Germany, United States, Italy, India, United Kingdom, China, France, Poland, Spain, Switzerland, Australia, Canada, Sao Tome and Principe, Brazil, Ireland, Japan, Belgium, Portugal, Singapore, Macao, Malaysia, Czechia, Mexico, Indonesia, Chile, Denmark, Sweden, Bulgaria, Netherlands, Finland, Hungary, Austria, Israel, Norway, Egypt, Argentina, Greece, Kenya, Thailand, Pakistan
Methanol is a clear, colorless, and flammable liquid that is widely used in various industrial and laboratory applications. It serves as a solvent, fuel, and chemical intermediate. Methanol has a simple chemical formula of CH3OH and a boiling point of 64.7°C. It is a versatile compound that is widely used in the production of other chemicals, as well as in the fuel industry.
Sourced in Germany, United States, United Kingdom, Italy, India, France, China, Australia, Spain, Canada, Switzerland, Japan, Brazil, Poland, Sao Tome and Principe, Singapore, Chile, Malaysia, Belgium, Macao, Mexico, Ireland, Sweden, Indonesia, Pakistan, Romania, Czechia, Denmark, Hungary, Egypt, Israel, Portugal, Taiwan, Province of China, Austria, Thailand
Ethanol is a clear, colorless liquid chemical compound commonly used in laboratory settings. It is a key component in various scientific applications, serving as a solvent, disinfectant, and fuel source. Ethanol has a molecular formula of C2H6O and a range of industrial and research uses.

More about "Hypromellose"

Hypromellose, also known as hydroxypropyl methylcellulose (HPMC), is a semisynthetic, partially substituted cellulose ether used as a pharmaceutical excipient and viscosity-increasing agent.
It is commonly employed in formulations for controlled drug release, ocular delivery, and topical applications.
Closely related to hypromellose are other cellulose derivatives like 2-hydroxypropyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin, which have similar applications in drug delivery and formulation.
These compounds can be used in conjunction with hypromellose to enhance solubility, stability, and bioavailability of active pharmaceutical ingredients (APIs).
Hypromellose research often involves the use of various solvents and reagents, such as DMSO, Tween 80, acetonitrile, sodium hydroxide, methanol, and ethanol.
These substances can be utilized to prepare, characterize, and evaluate hypromellose-based formulations and their performance.
PubCompare.ai's AI-driven platform helps researchers identify the most reproducible and accurate hypromellose research methods from literature, preprints, and patents, empowering reliable studies.
This seamless solution optimizes the research process, allowing scientists to explore and compare hypromellose-related protocols with ease and confidence.
Leveraging the insights gained, researchers can conduct high-quality studies that advance the understanding and applications of this versatile pharmaceutical excipient.